The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 15, 2021
Filed:
Jun. 18, 2015
Applicant:
Haldor Topsøe A/s, Kgs. Lyngby, DK;
Inventors:
Saravanamurugan Shunmugavel, Lyngby, DK;
Irantzu Sadaba Zubiri, Frederiksberg, DK;
Esben Taarning, Frederiksberg, DK;
Martin Spangsberg Holm, Oxford, GB;
Assignee:
Haldor Topsoe A/S, Lyngby, DK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01J 29/04 (2006.01); B01J 29/40 (2006.01); B01J 29/70 (2006.01); B01J 29/89 (2006.01); C01B 37/00 (2006.01); C01B 39/02 (2006.01); C01B 39/08 (2006.01); C01B 39/40 (2006.01); C01B 39/46 (2006.01); C07C 67/08 (2006.01); C07H 1/00 (2006.01); C07H 3/02 (2006.01); A23L 27/30 (2016.01); A23L 33/10 (2016.01); B01J 37/00 (2006.01); B01J 37/02 (2006.01); B01J 37/04 (2006.01); B01J 37/10 (2006.01); C07C 51/16 (2006.01); C07D 307/36 (2006.01);
U.S. Cl.
CPC ...
C07H 1/00 (2013.01); A23L 27/34 (2016.08); A23L 33/10 (2016.08); B01J 29/041 (2013.01); B01J 29/405 (2013.01); B01J 29/7049 (2013.01); B01J 29/7057 (2013.01); B01J 29/89 (2013.01); B01J 37/0018 (2013.01); B01J 37/0201 (2013.01); B01J 37/04 (2013.01); B01J 37/10 (2013.01); C01B 37/005 (2013.01); C01B 39/026 (2013.01); C01B 39/085 (2013.01); C01B 39/40 (2013.01); C01B 39/46 (2013.01); C07C 51/16 (2013.01); C07C 67/08 (2013.01); C07D 307/36 (2013.01); C07H 3/02 (2013.01); A23V 2002/00 (2013.01); B01J 2229/186 (2013.01); B01J 2229/37 (2013.01);
Abstract
A process for the preparation of Coxygenate compounds such as threose, erythrose or erythrulose starting from a composition comprising Coxygenate compounds such as formaldehyde, glycolaldehyde, glyoxal, pyruvaldehyde or acetol, wherein the process is carried out in the presence of a crystalline microporous material having a ring pore structure selected from an eight-membered ring pore structure or a ten-membered ring pore structure.